Depression & Anxiety in Chronic Disease

Depression and anxiety are highly prevalent in neurological and autoimmune diseases — not just psychological reactions, but driven by neuroinflammation, neurochemical changes, and shared pathological pathways.

Body System: Neuropsychiatric

Related Diseases

• Parkinson's Disease — Depression precedes motor symptoms in 40% of PD cases, driven by serotonergic and noradrenergic neuron loss.
• Alzheimer's Disease — Apathy and depression are among the most common neuropsychiatric symptoms, affecting 50-75% of patients.
• Autoimmune Diseases — Neuroinflammation drives depression in lupus, MS, and RA. Cytokine-induced sickness behavior.

Related Compounds

• Psilocybin
• Lion's Mane

Frequently Asked Questions

Why is depression common in Parkinson's disease?

PD depression isn't just a reaction to diagnosis — it's driven by degeneration of serotonergic (raphe nuclei) and noradrenergic (locus coeruleus) neurons alongside dopaminergic loss. It often precedes motor symptoms by years, serving as a potential prodromal marker. Treatment requires careful medication selection to avoid worsening motor symptoms.

Can psilocybin help with cancer-related distress?

Landmark trials at Johns Hopkins and NYU showed single-dose psilocybin produced rapid, sustained reductions in cancer-related anxiety and depression in 60-80% of patients. Effects lasted 6+ months. FDA granted 'breakthrough therapy' designation. It works through 5-HT2A receptor-mediated neuroplasticity and mystical-type experiences that shift perspective on mortality.